GILD vs SDGR · P/E 18, rev $29.44B vs rev $255.9M
Gilead Sciences Inc (GILD) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the GILD and SDGR stock pages for the full models.
Not investment advice.